Dianthus Therapeutics | MGTA - Nettoeinkommen

Aktienkurs
83.57
Täglich Wechseln
-3.59 -4.12%
Monatlich
5.19%
Jährlich
284.23%
Q2 Prognose
85.52




Nettoeinkommen Veränderung Datum
Akebia Therapeutics USD -12.24M 12.78M 2025-12
Alaunos Therapeutics USD -1.16M 108K 2025-09
Avita Medical AUD -11.62M 1.7M 2025-12
Celltrion KRW 331.35B 270.18B 2025-09
Cspc Pharmaceutical CNY 370.72M 592.81M 2025-12
Deva Holding AS TRY 583.98M 319.1M 2023-09
Dianthus Therapeutics USD -64.43M 27.67M 2025-12
Divis Laboratories Ltd INR 5.83B 1.06B 2025-12
IQVIA Holdings USD 514M 183M 2025-12
Kangmei Pharma CNY -3.82M 12.21M 2025-09
Knight Therapeutics CAD -3.79M 8.83M 2025-09
Laboratorios Farma EUR 103.69M 37.04M 2023-12
Malin Corporation EUR -1.1M 2.2M 2023-12
Medical Developments International AUD -226K 121K 2025-12
Moderna USD -200M 625M 2025-09
Neuren Pharmaceuticals AUD 15.4M 7.88M 2025-12
Organigram Holdings CAD 19.97M 57.93M 2025-12
Organon & Co USD 160M 15M 2025-09
Ovoca Bio EUR -765K 4.89M 2025-06
Pharma Mar EUR 59.66M 63.76M 2025-12
Qiagen NV USD 107.83M 22.21M 2025-12
Revvity USD 98.36M 51.71M 2025-12
Sartorius EUR 56.2M 37M 2026-03
Sino Biopharmaceutical CNY 3.39B 2.91B 2025-06
Tectonic Therapeutic USD -19.23M 186K 2025-12
Tilray USD -44.93M 44.61M 2025-09
Viatris USD -340.1M 211.9M 2025-12
Xeris Pharmaceuticals USD 11.08M 10.46M 2025-12
Zealand Pharma A/S -379.12M 25.12M 2025-12
Zz Pientze Pharmaceu CNY 687.04M 244.51M 2025-09